Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis
<h4>Background</h4> SHP2 is a latent biomarker for predicting the survivals of solid tumors. However, the current researches were controversial. Therefore, a meta-analysis is necessary to assess the prognosis of SHP2 on tumor patients. <h4>Materials and methods</h4> Searched...
Main Authors: | Jiupeng Zhou, Hui Guo, Yongfeng Zhang, Heng Liu, Quanli Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782321/?tool=EBI |
Similar Items
-
Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis.
by: Jiupeng Zhou, et al.
Published: (2022-01-01) -
Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?
by: Xun Chen, et al.
Published: (2024-03-01) -
A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
by: Jiupeng Zhou, et al.
Published: (2018-01-01) -
Teasing apart the multiple roles of Shp2 (Ptpn11) in spermatogenesis
by: Maher, G, et al.
Published: (2019) -
Loss of Ptpn11 (Shp2) drives satellite cells into quiescence
by: Joscha Griger, et al.
Published: (2017-05-01)